Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus ("RESET Real Life")

Prospective Clinical Study for Confirmation of Efficacy and Safety of Acoustic CR®-Neuromodulation by CE Marked ANM T30 CR®-System in a "Real Life" Patient Population With Chronic Tonal Tinnitus

Confirmation of efficacy and safety of acoustic CR®-neuromodulation for the treatment of chronic tinnitus patients using the CE marked ANM T30 CR®-system in a real life outpatient setting.

• Identification of early indicators for therapy success
• Comparison of different patient groups regarding: tinnitus severity, tinnitus duration, level of hearing loss, stimulation patterns, unilateral monotonal vs. all other complex forms
• Representative set of safety data in a broad patient spectrum
• Measurement of tinnitus burden (TBF-12 Questionnaire)
• Generation of longterm compliance data

Main Inclusion Criteria:

• symptomatic subjective tonal chronical (> 3 months) tinnitus
• <60dB hearing loss
• men and women ≥18 years old

Main Exclusion Criteria:

• serious neurologic
• psychiatric or internistic disease
• objective tinnitus
• Morbus Menière
• craniomandibular triggered tinnitus